1. Home
  2. CUE vs KLXE Comparison

CUE vs KLXE Comparison

Compare CUE & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • KLXE
  • Stock Information
  • Founded
  • CUE 2014
  • KLXE 2018
  • Country
  • CUE United States
  • KLXE United States
  • Employees
  • CUE N/A
  • KLXE N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • CUE Health Care
  • KLXE Energy
  • Exchange
  • CUE Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • CUE 91.9M
  • KLXE 89.2M
  • IPO Year
  • CUE 2018
  • KLXE N/A
  • Fundamental
  • Price
  • CUE $1.26
  • KLXE $4.54
  • Analyst Decision
  • CUE Strong Buy
  • KLXE Hold
  • Analyst Count
  • CUE 5
  • KLXE 1
  • Target Price
  • CUE $5.00
  • KLXE $4.50
  • AVG Volume (30 Days)
  • CUE 276.0K
  • KLXE 186.8K
  • Earning Date
  • CUE 03-10-2025
  • KLXE 03-05-2025
  • Dividend Yield
  • CUE N/A
  • KLXE N/A
  • EPS Growth
  • CUE N/A
  • KLXE N/A
  • EPS
  • CUE N/A
  • KLXE N/A
  • Revenue
  • CUE $9,532,000.00
  • KLXE $738,000,000.00
  • Revenue This Year
  • CUE $73.11
  • KLXE N/A
  • Revenue Next Year
  • CUE $11.02
  • KLXE $4.79
  • P/E Ratio
  • CUE N/A
  • KLXE N/A
  • Revenue Growth
  • CUE 149.53
  • KLXE N/A
  • 52 Week Low
  • CUE $0.45
  • KLXE $4.18
  • 52 Week High
  • CUE $2.58
  • KLXE $9.80
  • Technical
  • Relative Strength Index (RSI)
  • CUE 49.50
  • KLXE 35.29
  • Support Level
  • CUE $1.27
  • KLXE $5.04
  • Resistance Level
  • CUE $1.50
  • KLXE $6.16
  • Average True Range (ATR)
  • CUE 0.12
  • KLXE 0.51
  • MACD
  • CUE -0.01
  • KLXE -0.19
  • Stochastic Oscillator
  • CUE 53.73
  • KLXE 2.15

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: